Effect of a sharp serum oestradiol fall before HCG administration during ovarian stimulation in donors

Reproductive BioMedicine Online

Volumn 15, Issue 2, 2007, Pages 169-174

  Cobo, Ana ^a   Bosch, Ernesto ^a   Alvarez, Claudio ^a   de los Santos, María José ^a   Pellicer, Antonio ^a   Remohí, José ^a  

^a INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

Author keywords

Embryo quality; Oocyte donation; Oocyte quality; Serum oestradiol lowering

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; ESTRADIOL VALERATE; HUMAN MENOPAUSAL GONADOTROPIN; PROGEFFIK; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG DOSE INCREASE; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; NIDATION; OOCYTE DONATION; OVULATION INDUCTION; PREGNANCY RATE; QUALITY CONTROL;

EID: 34547952861     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60705-5     Document Type: Article

References (20)

1. Al-Shawaf T, Zosmer A, Hussain S et al. 2001 Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients. Human Reproduction 16, 24-30.
2. Ben-Nun I, Shulman A, Ghetler Y et al. 1993 The significance of 17 beta-estradiol levels in highly responding women during ovulation induction in IVF treatment: its impact and prognostic value with respect to oocyte maturation and treatment outcome. Journal of Assisted Reproduction and Genetics 10, 213-215.
3. Benadiva CA, Davis O, Kligman I et al. 1997 Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertility and Sterility 67, 724-727.
4. Ferraretti AP, Gianaroli L, Magli MC et al. 2004. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertility and Sterility 82, 1521-1526.
5. Fluker MR, Hooper WM, Yuzpe AA 1999 Withholding gonadotropins ('coasting') to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles. Fertility and Sterility 71, 294-301.
6. Isaza V, Garcia-Velasco JA, Aragones M et al. 2002 Oocyte and embryo quality after coasting: the experience from oocyte donation. Human Reproduction 17, 1777-1782.
7. Jones HW Jr, Acosta A, Andrews MC et al. 1983 The importance of the follicular phase to success and failure in in vitro fertilization. Fertility and Sterility 40, 317-321.
8. Khalaf Y, Taylor A, Braude P 2000 Low serum estradiol concentrations after five days of controlled ovarian hyperstimulation for in vitro fertilization are associated with poor outcome. Fertility and Sterility 74, 63-66.
9. Loumaye E, Engrand P, Howles CM et al. 1997 Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertility and Sterility 67, 889-899.
10. Mason HD, Willis DS, Beard RW et al. 1994 Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. Journal of Clinical Endocrinology and Metabolism 79, 1355-1360.
11. Melo MA, Meseguer M, Garrido N et al. 2006 The significance of premature luteinization in an oocyte-donation programme. Human Reproduction 21, 1503-1507.
12. Phelps JY, Levine AS, Hickman TN et al. 1998 Day 4 estradiol levels predict pregnancy success in women undergoing controlled ovarian hyperstimulation for IVF. Fertility and Sterility 69, 1015-1019.
13. Rao AJ, Ramachandra SG, Ramesh V et al. 2007 Establishment of the need for no estrogen during implantation in non-human primates. Reproductive BioMedicine Online 14, 563-571.
14. Remohi J, Gutierrez A, Cano F et al. 1995 Long oestradiol replacement in an oncyte donation programme. Human Reproduction 10, 1387-1391.
15. Scott LA, Smith S 1998 The successful use of pronuclear embryo transfers the day following oocyte retrieval. Human Reproduction 13, 1003-1013.
16. Sharara FI, McClamrock HD 1999 Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome. Human Reproduction 14, 2777-2782.
17. Sher G, Zouves C, Feinman M et al. 1995 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Human Reproduction 10, 3107-3109.
18. Soares SR, Troncoso C, Bosch E et al. 2005 Age and uterine receptiveness: predicting the outcome of oocyte donation cycles. Journal of Endocrinology and Metabolism 90, 4399-4404.
19. Styer AK, Jackson KV, Hornstein MD et al. 2005 Pregnancy outcomes in in vitro fertilization cycles with serum estradiol drop prior to human chorionic gonadotropin. International Journal of Gynecology and Obstetrics 89, 133-137.
20. Waldenstrom U, Kahn J, Marsk L et al. 1999 High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by 'prolonged coasting' of very hyperstimulated patients: a multicentre study. Human Reproduction 14, 294-297.